بدائل البحث:
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
changes decrease » largest decrease (توسيع البحث), change increases (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
significantly increased » significant increase (توسيع البحث)
increased decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
changes decrease » largest decrease (توسيع البحث), change increases (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
-
621
-
622
-
623
Remote learning: Preferences on recorded content. <i><i>Results displayed in percentages.</i></i>
منشور في 2025الموضوعات: -
624
-
625
Genomic downregulation of TGF β1 production in monocytes obtained after RZV administration. Panel A. The heatmap shows 16 genes on the y axis whose accessibility significantly changed between Days 0 and 90 after vaccination (FDR p < 0.1) in 8 participants shown on the x axis....
منشور في 2025"…The heatmap shows 16 genes on the y axis whose accessibility significantly changed between Days 0 and 90 after vaccination (FDR p < 0.1) in 8 participants shown on the x axis. …"
-
626
-
627
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
628
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
629
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
630
-
631
-
632
-
633
-
634
Activity of female and male <i>M. marinus</i> (left column) and <i>G. pulex</i> (right column).
منشور في 2025الموضوعات: -
635
-
636
-
637
-
638
-
639
-
640